Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2010-02-26FDA Approved: WELLBUTRIN SR — Supplemental Application (GlaxoSmithKline LLC)
The FDA approved a supplemental application for Wellbutrin SR (bupropion hydrochloride) submitted by GlaxoSmithKline LLC, updating the produ…
-
FDA approval · 2010-02-26FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for Venlafaxine hydrochloride from Dr. Reddy's Laboratories Limited under an ANDA. This confirms reg…
-
CLINICAL_TRIALS trial_result · 2010-02-26Clinical Trial Update: Magnetic Resonance Imaging Study of Geriatric Depression [NA]
Completed clinical trial investigating MRI findings in geriatric depression; results were posted.
-
CLINICAL_TRIALS trial_result · 2010-02-25Clinical Trial Update: Early Prediction of Fluoxetine Response [Phase 4]
Phase 4 trial assessing early predictors of fluoxetine response in adults with Major Depressive Disorder has completed. The sponsor is Kaohs…
-
FDA approval · 2010-02-16FDA Approved: PRISTIQ EXTENDED-RELEASE — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
FDA approved a supplemental application for Pristiq Extended-Release (desvenlafaxine succinate) by Wyeth/Pfizer, updating the product labeli…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-02-12Clinical Trial Update: Physical Activity or Usual Care in Preventing Weight Gain in Women With Stage I or Stage II Breast Cancer Undergoing Chemotherapy [Phase 1, Phase 2]
This completed Phase 1/2 trial examined whether a structured physical activity program prevents weight gain during chemotherapy in women wit…
-
CLINICAL_TRIALS trial_result · 2010-02-12Clinical Trial Update: Cymbalta for Depression as a Complication of Bereavement [Phase 4]
A Phase 4 study evaluating duloxetine (Cymbalta) for depression related to bereavement; the current status of the trial is unknown.
-
CLINICAL_TRIALS trial_result · 2010-02-09Clinical Trial Update: A Naturalistic Study of the Efficacy and Safety of Escitalopram in Treatment Resistant Depression [NA]
Clinical trial update detailing a naturalistic study of escitalopram for treatment-resistant depression; the status is unknown and no effica…
-
CLINICAL_TRIALS trial_result · 2010-02-08Clinical Trial Update: A Study Of Kappa Opioid Receptor Occupancy Of PF-04455242, Using PET (Positron Emission Tomography) [Phase 1]
Phase 1 PET study evaluating kappa opioid receptor occupancy of PF-04455242 in bipolar disorder and depression has been terminated. Sponsore…
-
CLINICAL_TRIALS research · 2010-02-04Clinical Trial Update: Neuropattern - Assessment of a Translational Diagnostic Tool for Depression, Adjustment- and Somatoform-disorders [NA]
This clinical trial update describes Neuropattern, a translational diagnostic tool being assessed for depression, adjustment disorders, and …
-
CLINICAL_TRIALS trial_result · 2010-02-01Clinical Trial Update: Clinical Pharmacogenomics of Antidepressant Response
A completed clinical trial from Taiwan investigating how genetic factors influence patient response to antidepressants in depression.
-
CLINICAL_TRIALS trial_result · 2010-01-28Clinical Trial Update: Treatment for Post-Stroke Depression [Phase 4]
Phase 4 clinical trial update on treatment for post-stroke depression completed with results posted in 2010.
-
CLINICAL_TRIALS trial_result · 2010-01-28Clinical Trial Update: Effect of Curcumin as Nutraceutical in Patients of Depression [NA]
Clinical trial evaluating curcumin as a nutraceutical for patients with Major Depressive Disorder has completed.
-
FDA approval · 2010-01-27FDA Approved: ZYPREXA ZYDIS — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for ZYPREXA ZYDIS (olanzapine) submitted by Eli Lilly and Company.
-
FDA approval · 2010-01-27FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for bupropion hydrochloride (generic) submitted by Amneal Pharmaceuticals of New York LLC under ANDA…
-
FDA approval · 2010-01-22FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental generic application for BUPROPION HYDROCHLORIDE by Amneal Pharmaceuticals of New York LLC under ANDA077415.
-
CLINICAL_TRIALS research · 2010-01-20Clinical Trial Update: Transcranial Magnetic Stimulation: Treatment Trial for Depressed Adolescents [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating transcranial magnetic stimulation for depression in adolescents has been terminated.
-
CLINICAL_TRIALS research · 2010-01-14Clinical Trial Update: Acupuncture for Residual Insomnia Associated With Major Depressive Disorder [NA]
This is a completed clinical trial evaluating acupuncture for residual insomnia in individuals with major depressive disorder.
-
CLINICAL_TRIALS trial_result · 2010-01-14Clinical Trial Update: Group Cognitive Behavioral Therapy (CBT) Intervention for Women With Mild to Moderate Depression [EARLY_Phase 1]
Clinical trial update for a group cognitive behavioral therapy (CBT) intervention in women with mild to moderate depression; an early-phase …
-
CLINICAL_TRIALS research · 2010-01-13Clinical Trial Update: Evaluating "Health at Every Size"(HAES) as an Alternative Obesity Treatment Model [NA]
This clinical trial update reports the completion of a study evaluating the Health at Every Size approach as an alternative obesity treatmen…
-
CLINICAL_TRIALS trial_result · 2010-01-13Clinical Trial Update: Efficacy and Safety of Escitalopram Doses up to 50mg in Treatment of MDD [Phase 4]
Phase 4 trial assessing the efficacy and safety of escitalopram at doses up to 50 mg for major depressive disorder. The study is completed.
-
CLINICAL_TRIALS trial_result · 2010-01-11Clinical Trial Update: Electroacupuncture for Major Depression [Phase 2]
This update reports the results of a Phase 2 clinical trial evaluating electroacupuncture as a treatment for major depressive disorder. The …
-
CLINICAL_TRIALS trial_result · 2010-01-11Clinical Trial Update: Treatment of Depressed Chronic Obstructive Pulmonary Disease Patients [NA]
A completed clinical trial studying treatment in patients with comorbid chronic obstructive pulmonary disease and major depression, with res…
-
FDA approval · 2010-01-06FDA Approved: EFFEXOR XR — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for Effexor XR (venlafaxine hydrochloride) submitted by Viatris Specialty LLC.
-
CLINICAL_TRIALS trial_result · 2010-01-06Clinical Trial Update: Light Therapy for Depression During Pregnancy [NA]
A completed clinical trial evaluating light therapy for major depressive disorder during pregnancy.